In Re: Levaquin Litigation
Sep 6, 2011
In this pharmaceutical product liability litigation bellwether jury trial proceedings, plaintiffs Robert Beare and Paul Gaffney alleged Johnson and Johnson of fraudulent concealment of the side effects of its antibiotic drug Levaquin and of bein...
May 12, 2011
Application for the premarket approval of Augment Bone Graft (Biomimetic).On May 12, 2011, the committee will discuss, make recommendations, and vote on information related to the premarket approval application (PMA) for the Augment Bone Graft, sp...
View Proceeding
Apr 29, 2011
Post-trial oral arguments scheduled for April 29, 2011. In this Pharmaceutical mergers and acquisition litgation proceeding, Plaintiff PharmAthene alleged Siga Technologies of breaching its obligations to negotiate in good faith a definitive licen...
View Proceeding
Apr 27, 2011
FDA Antiviral Drugs Advisory Committee will hear applications for Boceprevir and Telaprevir for treatment of Hepatitis C.On April 27, 2011, the committee will discuss a new drug application (NDA) 202-258, boceprevir (a hepatitis C virus protease i...
View Proceeding
PDL Biopharma v. Genentech [Premium]
Apr 21, 2011
In this Pharmaceutical Intellectual Property litigation hearing, Plaintiff PDL Biopharma sought to compel Hoffman La Roche Inc to continue paying royalties for certain drugs that infringe upon the plaintiffs biotechnology patents. Plaintiffs cou...
Mar 9, 2011
In this medical malpractice litigation En Blanc oral argument before the Nevada Supreme court, the plaintiffs counsels argued that nurses shouldnt be allowed to testify about how the hepatitis C outbreak occurred, whether through the dirty instr...
View Proceeding
Mar 8, 2011
In this pharmaceutical litigation proceeding, Plaintiff State of South Carolina alleged Jannsen, LP a subsidiary of Johnson and Johnson Inc of overcharging for its antipsychotic drug Risperdal (generically known as "Risperdone"). The alleged Medic...
View Proceeding